This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Testosterone deficiency (TD) therapy if prostate cancer

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Testosterone therapy and prostate cancer

Testosterone therapy can be offered to men with symptomatic TD and treated localised low-risk prostate cancer (Gleason score <8, stages 1-2, preoperative prostate specific antigen (PSA) <10ng/mL), as long as it is not started before 1 year of follow-up and they have no evidence of active disease (based on measured PSA level, DRE result and absence of metastases).

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page